Efavirenz Suppliers and Product Information

Efavirenz, also known as S-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one, is a benzoxazinone compound with the molecular formula C14H9ClF3NO2 and a molecular weight of 315.67. It was developed by DuPont Merck and is used as a first-line agent for HIV-1 infection.

Frequently Asked Questions about Efavirenz

Q: What is Efavirenz used for?

A: Efavirenz is a first-line agent used in the treatment of HIV-1 infection.

Q: What are some alternative names for Efavirenz?

A: Efavirenz was earlier known as L-743,726 and DMP-266.

Q: What is the chemical classification of Efavirenz?

A: Efavirenz is classified as a benzoxazinone compound.

Q: What should be considered when using Efavirenz?

A: When using Efavirenz, it's important to consider factors such as pharmacological aspects, indications and action, potential drug resistance, adverse reactions, and necessary precautions.